investordatabase.org

LYFE Capital

lyfecapital.com Direct investor

LYFE Capital is a healthcare investment platform with five global offices in Asia and the U.S. It invests in critical healthcare supply chain assets, specialized product platforms, and next-generation R&D services.

LYFE Capital is a private equity firm. It invests directly in companies, in healthcare, CDMO, surgical robotics and ADC. USD 2Bn under management, as it reports.

“we focus on investing in critical healthcare supply chain assets, specialized product platforms, and next-generation R&D services, allowing them to grow significant and resilient revenues from global mature markets.”

— LYFE Capital, own website
Layer
Direct investor
Type
Private equity
Stage
Not stated
Invests in
Asia, U.S.
Sectors
healthcare, CDMO, surgical robotics, ADC, CRO, medical devices, biopharma
Assets under management
USD 2Bn

Team, as LYFE Capital publishes it

  • Frances Chovanec Managing Director
  • Jack Chen Partner
  • William Chen Partner
  • Yao Li Ho Managing Director
  • Alvin Koh Investment Principal and Senior Director, APAC Business Development
  • Fong Ming Koh Principal
  • Peter Lee Managing Director
  • David Liu Director of Investor Relations

Names and roles exactly as listed on lyfecapital.com. Nothing else about these people is recorded.

Where this comes from

Every fact above was read from a page LYFE Capital publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.

Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.

Record 8653 · added 2026-09-29 · link last verified 2026-09-29 · confidence high

Similar investors

Listed under